STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 62 filers reported holding STEMLINE THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $182,000 | -28.3% | 37,646 | +57.3% | 0.00% | 0.0% |
| Q4 2019 | $254,000 | -33.9% | 23,929 | -19.9% | 0.00% | -66.7% |
| Q1 2019 | $384,000 | -10.9% | 29,864 | -34.2% | 0.01% | -25.0% |
| Q4 2018 | $431,000 | -12.4% | 45,413 | +48.1% | 0.01% | 0.0% |
| Q2 2018 | $492,000 | +154.9% | 30,656 | +148.0% | 0.01% | +166.7% |
| Q4 2017 | $193,000 | +20.6% | 12,360 | -33.9% | 0.00% | 0.0% |
| Q1 2017 | $160,000 | -40.1% | 18,700 | -25.1% | 0.00% | -40.0% |
| Q4 2016 | $267,000 | -51.9% | 24,954 | -51.3% | 0.01% | -50.0% |
| Q3 2016 | $555,000 | +46.8% | 51,243 | -8.3% | 0.01% | +25.0% |
| Q2 2016 | $378,000 | +62.9% | 55,854 | +12.0% | 0.01% | +60.0% |
| Q1 2016 | $232,000 | +46.8% | 49,860 | +272.1% | 0.01% | +66.7% |
| Q2 2015 | $158,000 | – | 13,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eventide Asset Management | 579,800 | $7,224,000 | 1.01% |
| VHCP Management, LLC | 71,000 | $884,000 | 0.40% |
| Healthcare Value Capital, LLC | 16,464 | $205,000 | 0.20% |
| CARL DOMINO INC | 22,196 | $277,000 | 0.15% |
| TFS CAPITAL LLC | 120,112 | $1,497,000 | 0.13% |
| Private Capital Advisors, Inc. | 31,064 | $387,000 | 0.12% |
| Artal Group S.A. | 170,000 | $2,118,000 | 0.08% |
| TimesSquare Capital Management, LLC | 801,225 | $9,983,000 | 0.06% |
| Baker Brothers Advisors | 338,671 | $4,220,000 | 0.05% |
| STONERIDGE INVESTMENT PARTNERS LLC | 19,399 | $242,000 | 0.04% |